Pancreatic Cancer Research

ResearcherNorth Sichuan Medical UniversityActive in the last 2 years

Yuehua Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-1343-7449; OpenAlex author ID A5101508336. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2026: 9 papers

Papers 9

  1. Targeting pancreatic cancer progression: The formononetin and salvianolic acid B combination suppresses JAK/STAT signaling via MBOAT2 downregulation. Co-author DOI 10.1016/j.joim.2026.05.003↗
  2. High SOX17 expression is correlated with favorable prognosis and CD8(+) TILs expression in patients with pancreatic cancer after curative resection. Co-author DOI 10.1016/j.tranon.2026.102859↗
  3. Leucine Aminopeptidase-Responsive Bioluminescent Probe for Point-of-Care Diagnosis of Pancreatic Cancer in Blood and Urine. Co-author DOI 10.1021/acs.analchem.6c03034↗
  4. Identification of a Small Molecule as Potential Hypoxia-Selective Agents by Reducing Membrane Localization of ENO1 in Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.jmedchem.5c03550↗
  5. ATP2B4 driven chromatin compaction exacerbates pancreatic cancer radiotherapy resistance. Co-author DOI 10.1038/s41420-026-03142-7↗
  6. Machine learning-based prognostic signature integrating mitochondrial function and programmed cell death patterns in pancreatic adenocarcinoma. Last author DOI 10.1038/s41598-026-51967-0↗
  7. PTK2/FAK inhibition triggers TMED9-mediated protective autophagy in pancreatic cancer cell via enhancing ERGIC-ERES contact. Co-author DOI 10.1080/15548627.2026.2676079↗
  8. Evaluating the prognostic significance of lymph node yield in resected pancreatic adenocarcinoma: a population-based study. Co-author DOI 10.1186/s12957-026-04475-4↗
  9. Indirect pharmacology of Amorphophallus rivieri Durieu in pancreatic ductal adenocarcinoma: immune-dependent macrophage remodeling and amino acid-related metab… Co-author DOI 10.21203/rs.3.rs-9321051/v1↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yan Deng · 1 shared paper, 2026 · strength 0.33
  2. Chia‐Jen Tsai · 1 shared paper, 2026 · strength 0.32
  3. Jun Yu · 1 shared paper, 2026 · strength 0.32
  4. Chuan Lan · 1 shared paper, 2026 · strength 0.32
  5. Chih-Ying Lu · 1 shared paper, 2026 · strength 0.32
  6. Xia Li · 1 shared paper, 2026 · strength 0.30
  7. Xiang Qian · 1 shared paper, 2026 · strength 0.30
  8. Qiao Liu · 1 shared paper, 2026 · strength 0.30
  9. Quan Zhang · 1 shared paper, 2026 · strength 0.29
  10. Yahui Ding · 1 shared paper, 2026 · strength 0.29
  11. Xiuchao Wang · 1 shared paper, 2026 · strength 0.29
  12. Tianyang Chen · 1 shared paper, 2026 · strength 0.29
  13. Bin Zhou · 1 shared paper, 2026 · strength 0.29
  14. Xinyu Qiu · 1 shared paper, 2026 · strength 0.29
  15. Hu Xiong · 1 shared paper, 2026 · strength 0.29
  16. Haitao Zhu · 1 shared paper, 2026 · strength 0.28
  17. Dongchao Xu · 1 shared paper, 2026 · strength 0.28
  18. Ying Xu · 1 shared paper, 2026 · strength 0.28
  19. Y F Luo · 1 shared paper, 2026 · strength 0.28
  20. Hsiang‐i Tsai · 1 shared paper, 2026 · strength 0.28
  21. Yu Wang · 1 shared paper, 2026 · strength 0.28
  22. Jin Chai · 1 shared paper, 2026 · strength 0.26
  23. Ming-Yue Wu · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.